Background: Evidence suggests that lower serum undercarboxylated osteocalcin (ucOC) may be negatively associated with cardiometabolic health. We investigated whether individuals with a suppression of ucOC following an increase in dietary vitamin K1 exhibit a relative worsening of cardiometabolic risk factors. Materials and Methods: Men (n = 20) and women (n = 10) aged 62 ± 10 years participated in a randomized, controlled, crossover study. The primary analysis involved using data obtained from participants following a high vitamin K1 diet (HK; 4-week intervention of increased leafy green vegetable intake). High and low responders were defined based on the median percent reduction (30%) in ucOC following the HK diet. Blood pressure (resting and 24 h), arterial stiffness, plasma glucose, lipid concentrations, and serum OC forms were assessed. Results: Following the HK diet, ucOC and ucOC/tOC were suppressed more (p < 0.01) in high responders (41 and 29%) versus low responders (12 and 10%). The reduction in ucOC and ucOC/tOC was not associated with changes in blood pressure, arterial stiffness, plasma glucose, or lipid concentrations in the high responders (p > 0.05). Discussion/Conclusion: Suppression of ucOC via consumption of leafy green vegetables has no negative effects on cardiometabolic health, perhaps, in part, because of cross-talk mechanisms.

1.
World Health Organization
.
World health statistics 2019: monitoring health for the SDGs; sustainable development goals
.
WHO
;
2019
.
2.
Struijk
EA
,
May
AM
,
Wezenbeek
NL
,
Fransen
HP
,
Soedamah-Muthu
SS
,
Geelen
A
, et al
Adherence to dietary guidelines and cardiovascular disease risk in the EPIC-NL cohort
.
Int J Cardiol
.
2014 Sep 20
;
176
(
2
):
354
9
. .
3.
Benjamin
EJ
,
Blaha
MJ
,
Chiuve
SE
,
Cushman
M
,
Das
SR
,
Deo
R
, et al
Heart disease and stroke statistics-2017 update: a report from the American Heart Association
.
Circulation
.
2017 Mar 07
;
135
(
10
):
e146
603
. .
4.
Blekkenhorst
LC
,
Prince
RL
,
Ward
NC
,
Croft
KD
,
Lewis
JR
,
Devine
A
, et al
Development of a reference database for assessing dietary nitrate in vegetables
.
Mol Nutr Food Res
.
2017 Aug
;
61
(
8
). .
5.
Bondonno
CP
,
Blekkenhorst
LC
,
Liu
AH
,
Bondonno
NP
,
Ward
NC
,
Croft
KD
, et al
Vegetable-derived bioactive nitrate and cardiovascular health
.
Mol Aspects Med
.
2018 Jun
;
61
:
83
91
. .
6.
Blekkenhorst
LC
,
Lewis
JR
,
Prince
RL
,
Devine
A
,
Bondonno
NP
,
Bondonno
CP
, et al
Nitrate-rich vegetables do not lower blood pressure in individuals with mildly elevated blood pressure: a 4-wk randomized controlled crossover trial
.
Am J Clin Nutr
.
2018 Jun 1
;
107
(
6
):
894
908
. .
7.
Kidd
PM
.
Vitamins D and K as pleiotropic nutrients: clinical importance to the skeletal and cardiovascular systems and preliminary evidence for synergy
.
Altern Med Rev
.
2010 Sep
;
15
(
3
):
199
222
.
8.
Booth
SL
,
Al Rajabi
A
.
Determinants of vitamin K status in humans
.
Vitam Horm
.
2008
;
78
:
1
22
. .
9.
Gundberg
CM
,
Lian
JB
,
Booth
SL
.
Vitamin K-dependent carboxylation of osteocalcin: friend or foe?
Adv Nutr
.
2012 Mar 1
;
3
(
2
):
149
57
. .
10.
Booth
SL
,
Centi
A
,
Smith
SR
,
Gundberg
C
.
The role of osteocalcin in human glucose metabolism: marker or mediator?
Nat Rev Endocrinol
.
2013 Jan
;
9
(
1
):
43
55
. .
11.
Price
PA
,
Williamson
MK
,
Lothringer
JW
.
Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone
.
J Biol Chem
.
1981 Dec 25
;
256
(
24
):
12760
6
.
12.
Hauschka
PV
,
Lian
JB
,
Cole
DE
,
Gundberg
CM
.
Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone
.
Physiol Rev
.
1989 Jul
;
69
(
3
):
990
1047
. .
13.
Lee
NK
,
Sowa
H
,
Hinoi
E
,
Ferron
M
,
Ahn
JD
,
Confavreux
C
, et al
Endocrine regulation of energy metabolism by the skeleton
.
Cell
.
2007 Aug 10
;
130
(
3
):
456
69
. .
14.
Polgreen
LE
,
Jacobs
DR
 Jr
,
Nathan
BM
,
Steinberger
J
,
Moran
A
,
Sinaiko
AR
.
Association of osteocalcin with obesity, insulin resistance, and cardiovascular risk factors in young adults
.
Obesity
.
2012 Nov
;
20
(
11
):
2194
201
. .
15.
Ling
Y
,
Gao
X
,
Lin
H
,
Ma
H
,
Pan
B
,
Gao
J
.
A common polymorphism rs1800247 in osteocalcin gene is associated with hypertension and diastolic blood pressure levels: the Shanghai Changfeng study
.
J Hum Hypertens
.
2016 Nov
;
30
(
11
):
679
84
. .
16.
Magni
P
,
Macchi
C
,
Sirtori
CR
,
Corsi Romanelli
MM
.
Osteocalcin as a potential risk biomarker for cardiovascular and metabolic diseases
.
Clin Chem Lab Med
.
2016 Oct 01
;
54
(
10
):
1579
87
. .
17.
Levinger
I
,
Brennan-Speranza
TC
,
Zulli
A
,
Parker
L
,
Lin
X
,
Lewis
JR
, et al
Multifaceted interaction of bone, muscle, lifestyle interventions and metabolic and cardiovascular disease: role of osteocalcin
.
Osteoporos Int
.
2017 Aug
;
28
(
8
):
2265
73
. .
18.
Millar
SA
,
Patel
H
,
Anderson
SI
,
England
TJ
,
O'Sullivan
SE
.
Osteocalcin, vascular calcification, and atherosclerosis: a systematic review and meta-analysis
.
Front Endocrinol
.
2017
;
8
:
183
. .
19.
Tacey
A
,
Qaradakhi
T
,
Brennan-Speranza
T
,
Hayes
A
,
Zulli
A
,
Levinger
I
.
Potential role for osteocalcin in the development of atherosclerosis and blood vessel disease
.
Nutrients
.
2018 Oct 4
;
10
(
10
):
1426
. .
20.
Sim
M
,
Lewis
JR
,
Prince
RL
,
Levinger
I
,
Brennan-Speranza
TC
,
Palmer
C
, et al
The effects of vitamin K-rich green leafy vegetables on bone metabolism: a 4-week randomised controlled trial in middle-aged and older individuals
.
Bone Rep
.
2020 Jun
;
12
:
100274
. .
21.
Gundberg
CM
,
Lian
JB
,
Gallop
PM
.
Measurements of gamma-carboxyglutamate and circulating osteocalcin in normal children and adults
.
Clin Chim Acta
.
1983 Feb 28
;
128
(
1
):
1
8
. .
22.
Levey
AS
,
Stevens
LA
,
Schmid
CH
,
Zhang
YL
,
Castro
AF
 3rd
,
Feldman
HI
, et al
A new equation to estimate glomerular filtration rate
.
Ann Intern Med
.
2009 May 5
;
150
(
9
):
604
12
. .
23.
Li
J
,
Zhang
H
,
Yang
C
,
Li
Y
,
Dai
Z
.
An overview of osteocalcin progress
.
J Bone Miner Metab
.
2016 Jul
;
34
(
4
):
367
79
. .
24.
Smith
C
,
Voisin
S
,
Al Saedi
A
,
Phu
S
,
Brennan-Speranza
T
,
Parker
L
, et al
Osteocalcin and its forms across the lifespan in adult men
.
Bone
.
2020 Jan
;
130
:
115085
. .
25.
Tan
A
,
Gao
Y
,
Yang
X
,
Zhang
H
,
Qin
X
,
Mo
L
, et al
Low serum osteocalcin level is a potential marker for metabolic syndrome: results from a Chinese male population survey
.
Metab Clin Exp
.
2011 Aug
;
60
(
8
):
1186
92
. .
26.
Oosterwerff
MM
,
van Schoor
NM
,
Lips
P
,
Eekhoff
EM
.
Osteocalcin as a predictor of the metabolic syndrome in older persons: a population-based study
.
Clin Endocrinol
.
2013 Feb
;
78
(
2
):
242
7
. .
27.
Lerchbaum
E
,
Schwetz
V
,
Pilz
S
,
Grammer
TB
,
Look
M
,
Boehm
BO
, et al
Association of bone turnover markers with mortality in men referred to coronary angiography
.
Osteoporos Int
.
2013 Apr
;
24
(
4
):
1321
32
. .
28.
Lerchbaum
E
,
Schwetz
V
,
Pilz
S
,
Boehm
BO
,
März
W
.
Association of bone turnover markers with mortality in women referred to coronary angiography: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
.
Osteoporos Int
.
2014 Feb
;
25
(
2
):
455
65
. .
29.
Ling
Y
,
Wang
Z
,
Wu
B
,
Gao
X
.
Association of bone metabolism markers with coronary atherosclerosis and coronary artery disease in postmenopausal women
.
J Bone Miner Metab
.
2018 May
;
36
(
3
):
352
63
. .
30.
Blekkenhorst
LC
,
Bondonno
NP
,
Liu
AH
,
Ward
NC
,
Prince
RL
,
Lewis
JR
, et al
Nitrate, the oral microbiome, and cardiovascular health: a systematic literature review of human and animal studies
.
Am J Clin Nutr
.
2018 Apr 1
;
107
(
4
):
504
22
. .
31.
Brennan-Speranza
TC
,
Conigrave
AD
.
Osteocalcin: an osteoblast-derived polypeptide hormone that modulates whole body energy metabolism
.
Calcif Tissue Int
.
2015 Jan
;
96
(
1
):
1
10
. .
32.
Rossi
M
,
Battafarano
G
,
Pepe
J
,
Minisola
S
,
Del Fattore
A
.
The endocrine function of osteocalcin regulated by bone resorption: a lesson from reduced and increased bone mass diseases
.
Int J Mol Sci
.
2019 Sep 11
;
20
(
18
):
4502
.
33.
Kanazawa
I
,
Yamaguchi
T
,
Yamauchi
M
,
Yamamoto
M
,
Kurioka
S
,
Yano
S
, et al
Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus
.
Osteoporos Int
.
2011 Jan
;
22
(
1
):
187
94
. .
34.
Alfadda
AA
,
Masood
A
,
Shaik
SA
,
Dekhil
H
,
Goran
M
.
Association between osteocalcin, metabolic syndrome, and cardiovascular risk factors: role of total and undercarboxylated osteocalcin in patients with type 2 diabetes
.
Int J Endocrinol
.
2013
;
2013
:
197519
. .
35.
Parker
L
,
Lin
X
,
Garnham
A
,
McConell
G
,
Stepto
NK
,
Hare
DL
, et al
Glucocorticoid-induced insulin resistance in men is associated with suppressed undercarboxylated osteocalcin
.
J Bone Miner Res
.
2019 Jan
;
34
(
1
):
49
58
.
36.
Tacey
A
,
Parker
L
,
Yeap
BB
,
Joseph
J
,
Lim
EM
,
Garnham
A
, et al
Single-dose prednisolone alters endocrine and haematologic responses and exercise performance in men
.
Endocr Connect
.
2019 Feb
;
8
(
2
):
111
9
. .
37.
Kapustin
AN
,
Shanahan
CM
.
Osteocalcin: a novel vascular metabolic and osteoinductive factor?
Arterioscler Thromb Vasc Biol
.
2011 Oct
;
31
(
10
):
2169
71
. .
38.
Cheng
HM
,
Wang
JJ
,
Chen
CH
.
The role of vascular calcification in heart failure and cognitive decline
.
Pulse
.
2018 Mar
;
5
(
1–4
):
144
53
. .
39.
Braam
LA
,
Hoeks
AP
,
Brouns
F
,
Hamulyák
K
,
Gerichhausen
MJ
,
Vermeer
C
.
Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study
.
Thromb Haemost
.
2004 Feb
;
91
(
2
):
373
80
. .
40.
Shea
MK
,
O’Donnell
CJ
,
Hoffmann
U
,
Dallal
GE
,
Dawson-Hughes
B
,
Ordovas
JM
, et al
Vitamin K supplementation and progression of coronary artery calcium in older men and women
.
Am J Clin Nutr
.
2009 Jun
;
89
(
6
):
1799
807
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.